Possibilities of using telemedicine methods in the management of lipitension
Authors:
Adriána Jarolímková 1,2,3; Patrik Buček 1; Štefan Tóth 1,2,3
Authors‘ workplace:
Kardiologická ambulancia, Kardiocomp s. r. o., Košice
1; SLOVACRIN, LF UPJŠ v Košiciach
2; MEDIPARK, LF UPJŠ v Košiciach
3
Published in:
AtheroRev 2025; 10(1): 45-51
Category:
Reviews
Overview
Currently, despite significant advances in the treatment of acute cardiovascular (CV) events, rates of blood pressure control and dyslipidemia, as major risk factors for CV disease (CVD), are stagnant and traditional approaches often fail. Initiatives in digital medicine have already started to emerge before the COVID-19 pandemic fundamentally impacted the way healthcare is delivered. Arterial hypertension is an ideal candidate for remote management, and digital solutions in this area are rapidly gaining traction. Studies have shown that telemedicine methods significantly reduce both systolic and diastolic blood pressure of patients and help improve achievement of target blood pressure values and adherence to therapy. However, it was also shown that mHealth (mobile Health) methods had to be associated with concurrent consultation with a healthcare professional. Self-monitoring or “selfcouching” apps that worked on passive data collection did not show the above results. It has also been shown that there are many barriers to the implementation of these technologies, such as instrumentation (use of validated blood pressure monitors and measurement methods), financial (health insurance reimbursement, cost to the patient), legislative (mainly privacy) and also the lack of standardization in this area. Telemedicine methods have also started to be applied in the management of dyslipidemia, where it has been found that remote patient management with simultaneous information to the patient about his/her CV risk can significantly help to improve adherence to therapy and in achieving target values of lipid parameters.
Sources
Timmis A, Vardas P, Townsend N et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J 2022; 43(8): 716–799. Dostupné z DOI: <https://doi:10.1093/eurheartj/ehab892>.
Williams B, Mancia G, Spiering W et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018; 39(33): 3021–3104. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehy339>.
Šimková A, Vachulová A. Nevyhnutná potreba zmeny rutinného prístupu v manažmente pacienta s artériovou hypertenziou a dyslipidémiou. Obraz reálnej praxe – DISCOVERY. Via practica 2024; 21(3): 120–124.
Privett N, Guerrier S. Estimation of the time needed to deliver the 2020 USPSTF preventive care recommendations in primary care. Am J Public Health 2021; 111(1): 145–149. Dostupné z DOI: <http://dx.doi.org/10.2105/AJPH.2020.305967>.
McEvoy JW, McCarthy CP, Bruno RM et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024; 45(38): 3912–4018. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehae178>.
Mancia G, Kreutz R, Brunström M et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens 2023; 41(12): 1874–2071.Dostupné z DOI: <http://dx.doi.org/10.1097/HJH.0000000000003480>. Erratum in Erratum. J Hypertens 2024; 42(1): 194. Dostupné z DOI: <http://dx.doi.org/10.1097/HJH.0000000000003621>.
Ray KK, Molemans B, Schoonen WM et al. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study. Eur J Prev Cardiol 2021; 28(11): 1279–1289. Dostupné z DOI: <http://dx.doi.org/10.1093/eurjpc/zwaa047>.
Toth S, Turek M, Pella D. Success in achieving LDL-C target values in a high-risk population in Slovakia: the Slovak Lipid retrospective study. Archi Med Sci 2023. Dostupné z DOI: <https://doi.org/10.5114/aoms/170961>.
Deng L, Wu Q, Ding F et al. The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis. Front Cardiovasc Med 2022; 9:1020744. Dostupné z DOI: <https://doi.org/10.3389/fcvm.2022.1020744>.
Vaseekaran M, Kaese S, Görlich D et al. WATCH-BPM—Comparison of a WATCH-Type Blood Pressure Monitor with a Conventional Ambulatory Blood Pressure Monitor and Auscultatory Sphygmomanometry. Sensors (Basel) 2023; 23(21): 8877. Dostupné z DOI: <https://doi.org/10.3390/s23218877>. PMID: 37960576; PMCID: PMC10650650.
Zheng Q, Li Y, Pan J et al. A feasibility study on biometric identification using multimodal signal analysis of photoplethysmogram and phonocardiogram. In: Proceedings of the ACM International Conference on Artificial Intelligence in Medicine (AI-Med '23). Association for Computing Machinery 2024: p. 58–62. Dostupné z DOI: <https://doi.org/10.1145/3703847.3703858>.
Kim J, Chang SA, Park SW. First-in-Human Study for Evaluating the Accuracy of Smart Ring Based Cuffless Blood Pressure Measurement. J Korean Med Sci 2024; 39(2): e18. Dostupné z DOI: <https://doi.org/10.3346/jkms.2024.39.e18>.
Kireev D, Kampfe J, Hall A et al. Graphene electronic tattoos 2.0 with enhanced performance, breathability and robustness. NPJ 2D Mater Appl 2022; 6: 46. Dostupné z WWW: <https://www.nature.com/articles/s41699–022–00324–6>.
Leong AY, Makowsky MJ. Quality of Blood Pressure Tracking Apps for the iPhone: Content Analysis and Evaluation of Adherence With Home Blood Pressure Measurement Best Practices. JMIR Mhealth Uhealth 2019; 7(4): e10809. Dostupné z DOI: <https://doi.org/10.2196/10809>.
Sakima A, Akagi Y, Akasaki Y et al. Effectiveness of digital health interventions for telemedicine/telehealth for managing blood pressure in adults: a systematic review and meta-analysis. Hypertens Res 2025; 48: 478–491. Dostupné z DOI: <https://doi.org/10.1038/s41440–024–01792–7>.
Kario K, Nomura A, Harada N et al. Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial. Eur Heart J 2021; 42(40): 4111–4122. Dostupné z DOI: <https://doi.org/10.1093/eurheartj/ehab559>.
McManus RJ, Little P, Stuart B et al (HOME BP investigators). Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ 2021; 372: m4858. Dostupné z DOI: <http://doi: 10.1136/bmj.m4858>.
Meng F, Jiang Y, Yu P et al. Effect of health coaching on blood pressure control and behavioral modification among patients with hypertension: A systematic review and meta-analysis of randomized controlled trials. Int J Nurs Stud 2023; 138: 104406. Dostupné z DOI: <http://doi/10.1016/j.ijnurstu.2023.104406>.
Tran K, Mak M, Kuyper LM et al. Home Blood Pressure Telemonitoring Technology for Patients With Asymptomatic Elevated Blood Pressure Discharged From the Emergency Department: Pilot Study. JMIR Form Res 2024; 8: e49592. Dostupné z DOI: <http://doi/10.2196/49592>.
Saafi M, Bel Haj Ali K, Dhaoui R et al. Phone-based telemonitoring of arterial hypertension versus usual care: the HOROSCOPE study. Hypertens Res 2024. Dostupné z DOI: <http://doi/10.1038/s41440–024–02018–6>.
Sanchez-Ramirez DC, Pol M, Loewen H et al. Effect of telemonitoring and telerehabilitation on physical activity, exercise capacity, health-related quality of life and healthcare use in patients with chronic lung diseases or COVID-19: a scoping review. J Telemed Telecare 2024; 30(7): 1097–1115. Dostupné z DOI: <http://doi/10.1177/1357633X23121108>.
Persell SD, Peprah YA, Lipiszko D et al. Effect of home blood pressure monitoring via a smartphone hypertension coaching application or tracking application on adults with uncontrolled hypertension: a randomized clinical trial. JAMA Netw Open 2020; 3(3): e200255. Dostupné z DOI: <http://doi: 10.1001/jamanetworkopen.2020.0255>.
Schubert TJ, Clegg K, Karalis D et al. Impact of telehealth on the current and future practice of lipidology: a scoping review. J Clin Lipidol 2013; 17(1): 40–54. Dostupné z DOI: <http://dx.doi.org/10.1016/j.jacl.2022.12.003>.
Tan NC, Tyagi S, Lee CS et al. Effectiveness of an algorithm-driven home telemonitoring system on the metabolic control and self-care behaviour of Asian adults with type-2 diabetes mellitus: A randomised controlled trial. J Telemed Telecare 2023; 1357633X231203490. Dostupné z DOI: <http://dx.doi.org/10.1177/1357633X231203490>.
Hodgkinson JA, Lee MM, Milner S et al. Accuracy of blood-pressure monitors owned by patients with hypertension (ACCU-RATE study): a cross-sectional, observational study in central England. Br J Gen Pract 2020; 70(697): e548-e554. Dostupné z DOI: <http://dx.doi.org/10.3399/bjgp20X709497>.
Margolis KL, Bergdall AR, Crain AL et al. Comparing pharmacist-led telehealth care and clinic-based care for uncontrolled high blood pressure: the hyperlink 3 pragmatic cluster-randomized trial. Hypertension 2022; 79(12): 2708–2720. Dostupné z DOI: <http://dx.doi.org/10.1161/HYPERTENSIONAHA.122.19690>.
Ang WC, Khalid K, Che Z et al. Evaluating Telemedicine Perception and Readiness among Healthcare Workers in Malaysia. Perspect Health Inf Manag 2023; 20(3): 1i. PMCID: PMC10701634.
Queiroz C, Guerreiro C, Oliveira-Santos M et al. Digital health and cardiovascular healthcare professionals in Portugal: Current status, expectations and barriers to implementation. Rev Port Cardiol 2024; 43(8): 459–467.
Sabia A, Di Martino B. Towards a patterns-driven cloud edge continuum architecture for eHealth. In: Proceedings of the International Conference on Advanced Information Networking and Applications. Cham: Springer Nature Switzerland 2024: 338–346. Dostupné z DOI: <http://dx.doi.org/10.1007/978–3-031–57931–8_33>.
Omboni S. Telemedicine for hypertension management: where we stand, where we are headed. Conn Health 2022; 1(2): 85–97. Dostupné z DOI: <http://dx.doi.org/10.20517/ch.2022.09>.
Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsArticle was published in
Athero Review
2025 Issue 1
Most read in this issue
- Targeting lipoprotein(a): modification of cardiovascular risk and current treatment options
- SAA Consensus Statement EAS 2021: Triglyceride-rich lipoproteins and their remnant particles – a review of metabolism, role in atherosclerotic cardiovascular disease, and new therapeutic strategies
- Cardiovascular risk in obese individuals: how to keep it under control?
- The use of fenofibrate in the prevention of diabetic retinopathy progression: an interdisciplinary consensus